Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes

NCT03578835 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03578835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03578835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2017
Completion date
June 30, 2019
Enrollment
6,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection, septic shock